by TractManager | Jun 12, 2024 | Emerging Technology Report
Tabelecleucel (Pierre Fabre Laboratories and Atara Biotherapeutics Inc.) is an investigational allogenic T cell immunotherapy proposed for treatment of relapsed or refractory Ebstein-Barr virus-positive posttransplant lymphoproliferative disease.
by TractManager | Jun 11, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma in the surgical repair of Achilles tendon rupture.
by TractManager | Jun 10, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma for treatment of Achilles tendinopathy.
by TractManager | Jun 4, 2024 | Emerging Technology Report
The Valeda Light Delivery System (formerly LT-300; LumiThera Inc.) is a photobiomodulation device that delivers yellow, red, and near-infrared light to the eyes for treatment of dry age-related macular degeneration.
by TractManager | Jun 3, 2024 | Emerging Technology Report
Exagamglogene autotemcel (Casgevy; Vertex Pharmaceuticals and CRISPR Therapeutics) is an autologous, genome-edited, hematopoietic stem cell-based gene therapy indicated for the treatment of sickle cell disease (SCD) in patients aged 12 years and older with recurrent...
Recent Comments